[HTML][HTML] Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer?
YS Li, HC Ren, JH Cao - International journal of …, 2022 - spandidos-publications.com
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is highly infectious and
pathogenic. Among patients with severe SARS‑CoV‑2‑caused by corona virus disease 2019 …
pathogenic. Among patients with severe SARS‑CoV‑2‑caused by corona virus disease 2019 …
[HTML][HTML] COVID and lung cancer
Abstract Purpose of Review Since the past year, the fast spread of coronavirus disease 2019
(COVID-19) has represented a global health threat, especially for cancer patients, that has …
(COVID-19) has represented a global health threat, especially for cancer patients, that has …
Challenges posed by COVID‐19 in cancer patients: a narrative review
A novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),
was identified as the causative agent of coronavirus disease 2019 (COVID‐19). In early …
was identified as the causative agent of coronavirus disease 2019 (COVID‐19). In early …
[HTML][HTML] Interactions between COVID-19 and lung cancer: lessons learned during the pandemic
DJH Bian, S Sabri, BS Abdulkarim - Cancers, 2022 - mdpi.com
Simple Summary COVID-19 is a respiratory infectious disease caused by the coronavirus
SARS-CoV-2. Lung cancer is the leading cause of all cancer-related deaths worldwide. As …
SARS-CoV-2. Lung cancer is the leading cause of all cancer-related deaths worldwide. As …
The role of endotheliitis in COVID‐19: Real‐world experience of 11 190 patients and literature review for a pathophysiological map to clinical categorisation
Objective COVID‐19 may yield a variety of clinical pictures, differing from pneumonitis to
Acute Respiratory Distress Syndrome along with vascular damage in the lung tissue, named …
Acute Respiratory Distress Syndrome along with vascular damage in the lung tissue, named …
[HTML][HTML] Immune checkpoint inhibitor-related pneumonitis and COVID-19: a case-matched comparison of CT findings
Objectives To compare the radiological findings of immune checkpoint inhibitor-related
pneumonitis (IRP) and COVID-19 pneumonia, evaluating the potential of the CO-RADS …
pneumonitis (IRP) and COVID-19 pneumonia, evaluating the potential of the CO-RADS …
[HTML][HTML] Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model
CS Curran, X Cui - Frontiers in Immunology, 2024 - frontiersin.org
Introduction Because prior immune checkpoint inhibitor (ICI) therapy in cancer patients
presenting with COVID-19 may affect outcomes, we investigated the beta-coronavirus …
presenting with COVID-19 may affect outcomes, we investigated the beta-coronavirus …
[HTML][HTML] Lights and shadows on managing immune checkpoint inhibitors in oncology during the COVID-19 era
C Burgaletto, O Brunetti, A Munafò, R Bernardini… - Cancers, 2021 - mdpi.com
Simple Summary The potential interference at the immune response level between COVID-
19 and cancer therapy raises key clinical questions and points out scientific issues that need …
19 and cancer therapy raises key clinical questions and points out scientific issues that need …
Tailored treatment strategies for cancer patients during COVID-19 pandemic
H Abdelkader, M El Kassas - reports of Practical Oncology …, 2022 - journals.viamedica.pl
The global pandemic of respiratory disease caused by the novel human coronavirus (SARS-
CoV-2) has caused indefinite global distress, uncertainty, and disturbance. This pandemic …
CoV-2) has caused indefinite global distress, uncertainty, and disturbance. This pandemic …
[HTML][HTML] Imaging diagnosis of bronchogenic carcinoma (the forgotten disease) during times of COVID-19 pandemic: Current and future perspectives
R Reddy - World Journal of Clinical Oncology, 2021 - ncbi.nlm.nih.gov
Patients with bronchogenic carcinoma comprise a high-risk group for coronavirus disease
2019 (COVID-19), pneumonia and related complications. Symptoms of COVID-19 related …
2019 (COVID-19), pneumonia and related complications. Symptoms of COVID-19 related …